Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 11:10 am Purchase | 2025-01-30 | 13G | Elicio Therapeutics, Inc. ELTX | Knoll Capital Management, LLC | 630,915 5.200% | 630,915 (New Position) | Filing History |
| 2024-11-20 1:48 pm Purchase | 2024-11-14 | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management, LLC | 5,881,879 15.000% | 2,000,000 (+51.52%) | Filing History |
| 2024-01-16 10:45 am Purchase | 2023-12-26 | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management, LLC | 3,881,879 9.967% | 1,397,604 (+56.26%) | Filing History |
| 2023-10-04 3:22 pm Purchase | 2023-09-28 | 13G | Aldeyra Therapeutics, Inc. ALDX | Knoll Capital Management, LLC | 3,595,916 6.100% | 3,595,916 (New Position) | Filing History |
| 2023-06-20 11:04 am Purchase | 2023-05-31 | 13G | HOOKIPA Pharma Inc. HOOK | Knoll Capital Management, LLC | 551,739 6.800% | 551,739 (New Position) | Filing History |
| 2023-01-23 1:10 pm Purchase | 2023-01-04 | 13G | Applied Therapeutics, Inc. APLT | Knoll Capital Management, LLC | 3,450,000 7.180% | 3,450,000 (New Position) | Filing History |
| 2021-06-14 12:58 pm Purchase | 2021-05-19 | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management, LLC | 2,484,275 10.400% | 742,912 (+42.66%) | Filing History |
| 2021-02-16 2:48 pm Purchase | 2020-12-31 | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management, LLC | 1,741,363 8.300% | 1,741,363 (New Position) | Filing History |
| 2020-08-14 4:13 pm Purchase | 2020-04-23 | 13G | Orgenesis Inc. ORGS | Knoll Capital Management, LLC | 131,636 5.900% | 131,636 (New Position) | Filing History |
| 2020-02-14 4:15 pm Purchase | 2020-02-14 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management, LLC | 168,196 7.060% | 2,000 (+1.20%) | Filing History |